Session Information

  • WCLC 2020

    2020 World Conference on Lung Cancer

    Conference Program for the 2020 World Conference on Lung Cancer in Singapore


    Presentation Date(s):  
    • January 28 - 31, 2021
    • Total Presentations: 1623

    All times listed are in Singapore time (GMT+8)

    PL - Plenary
    PS - Presidential Symposium
    ES - Education Session
    OA - Oral Session
    MA - Mini Oral Session
    FP - Featured Posters
    P - Posters

Filter Results:

Show Only CME Accredited Sessions

  • +

    FP13 - Immunotherapy (Phase II/III Trials)

    • Type: Posters (Featured)
    • Track: Immunotherapy (Phase II/III Trials)
    • +

      FP13.01 - 5-Year Survival Update From KEYNOTE-010: Pembrolizumab Versus Docetaxel in Previously Treated, PD-L1–Positive Advanced NSCLC

      00:00 - 00:00  |  Presenting Author(s): Roy S. Herbst

      • Abstract

      Loading...

    • +

      FP13.02 - Pembrolizumab + Pemetrexed-Platinum vs Pemetrexed-Platinum for Metastatic NSCLC: 4-Year Follow-up From KEYNOTE-189

      00:00 - 00:00  |  Presenting Author(s): Jhanelle Elaine Gray

      • Abstract

      Loading...

    • +

      FP13.03 - IMpower110: Updated OS Analysis of Atezolizumab vs Platinum-Based Chemotherapy as First-Line Treatment in PD-L1–Selected NSCLC

      00:00 - 00:00  |  Presenting Author(s): Roy S. Herbst

      • Abstract

      Loading...

    • +

      FP13.04 - KEYNOTE-042 3-Year Survival Update: 1L Pembrolizumab vs Platinum-Based Chemotherapy for PD-L1+ Locally Advanced/Metastatic NSCLC

      00:00 - 00:00  |  Presenting Author(s): Byoung Chul Cho

      • Abstract

      Loading...

  • +

    FP14 - Targeted Therapy - Clinically Focused

    • Type: Posters (Featured)
    • Track: Targeted Therapy - Clinically Focused
    • +

      FP14.02 - A Phase II Study of Osimertinib versus Combination of Osimertinib and Chemotherapy for EGFR and T790M-Mutation Positive NSCLC

      00:00 - 00:00  |  Presenting Author(s): Atsuto Mouri

      • Abstract

      Loading...

    • +

      FP14.03 - Osimertinib + Savolitinib in pts with EGFRm MET-Amplified/Overexpressed NSCLC: Phase Ib TATTON Parts B and D Final Analysis

      00:00 - 00:00  |  Presenting Author(s): Ji-Youn Han

      • Abstract

      Loading...

    • +

      FP14.04 - Resistance to MET Inhibition in MET Driven NSCLC and Response after Switching from Type I to Type II MET Inhibitors

      00:00 - 00:00  |  Presenting Author(s): Richard Riedel

      • Abstract

      Loading...

    • +

      FP14.05 - LIBRETTO-431: Selpercatinib in Treatment-Naïve Patients with RET Fusion-Positive Non-Small Cell Lung Cancer (NSCLC).

      00:00 - 00:00  |  Presenting Author(s): Koichi Goto

      • Abstract

      Loading...

    • +

      FP14.06 - Multicenter Analysis of Mechanisms of Resistance to Osimertinib (O) in EGFR Mutated NSCLC: An ATOMIC Registry Study

      00:00 - 00:00  |  Presenting Author(s): Joshua M. Bauml

      • Abstract

      Loading...

    • +

      FP14.07 - Combination Osimertinib plus Selpercatinib for EGFR-mutant Non-Small Cell Lung Cancer (NSCLC) with Acquired RET fusions

      00:00 - 00:00  |  Presenting Author(s): Julia K Rotow

      • Abstract

      Loading...

    • +

      FP14.08 - Cabozantinib Plus Atezolizumab in NSCLC Patients Previously Treated with a Checkpoint Inhibitor: Results from COSMIC 021

      00:00 - 00:00  |  Presenting Author(s): Joel W Neal

      • Abstract

      Loading...

    • +

      FP14.09 - Tepotinib Safety in MET Exon 14 (METex14) Skipping NSCLC: Updated Results from the VISION Trial

      00:00 - 00:00  |  Presenting Author(s): Rémi Veillon

      • Abstract

      Loading...

    • +

      FP14.10 - Efficacy and Safety of Selpercatinib (LOXO-292) in East Asian Patients with RET Fusion-Positive NSCLC

      00:00 - 00:00  |  Presenting Author(s): Herbert H Loong

      • Abstract

      Loading...

    • +

      FP14.11 - Icotinib versus Chemotherapy as Adjuvant Treatment for Stage II–IIIA EGFR-Mutant NSCLC (EVIDENCE): A Randomized, Open-Label, Phase 3 Study

      00:00 - 00:00  |  Presenting Author(s): Caicun Zhou

      • Abstract

      Loading...

    • +

      FP14.12 - Quality of Life and Subgroup Analysis in a Phase 3 Randomized Study of Ensartinib vs Crizotinib in ALK–Positive NSCLC Patients: eXalt3.

      00:00 - 00:00  |  Presenting Author(s): Yi-long Wu

      • Abstract

      Loading...

    • +

      FP14.13 - Molecular Characterisation and Clinical Outcomes in RET Rearranged Non-Small Cell Lung Cancer (NSCLC)

      00:00 - 00:00  |  Presenting Author(s): Aaron C Tan

      • Abstract

      Loading...

    • +

      FP14.14 - Post Hoc Analyses from an Open Label, Multi-Centre, ASTRIS Trial of Efficacy of Osimertinib for CNS Metastases with T790M-Positive Advanced NSCLC

      00:00 - 00:00  |  Presenting Author(s): Beung-Chul Ahn

      • Abstract

      Loading...

    • +

      FP14.15 - Neratinib-Based Combination Therapy in HER2-Mutant Lung Adenocarcinomas: Findings from two International Phase 2 Studies.

      00:00 - 00:00  |  Presenting Author(s): Bob T. Li

      • Abstract

      Loading...

    • +

      FP14.16 - Phase 2 Trial of the Alternating Therapy with Osimertinib and Afatinib for Treatment-Naive Patients with EGFR-Mutated Advanced Non–Small Cell Lung Cancer (WJOG10818L/Alt Trial)

      00:00 - 00:00  |  Presenting Author(s): Hidetoshi Hayashi

      • Abstract

      Loading...

    • +

      FP14.17 - Efficacy and Safety of Pralsetinib in Chinese Patients with Advanced RET Fusion+ Non-Small Cell Lung Cancer after Platinum-Based Chemotherapy

      00:00 - 00:00  |  Presenting Author(s): Qing Zhou

      • Abstract

      Loading...

  • +

    P01 - Antibody Drug Conjugates, Novel Therapeutics and Cytotoxics

    • 00:00 - 00:00
    • 1/28/2021
    • Location: ePoster Hall
    • Not for CME Credit
    • Type: Posters
    • Track: Antibody Drug Conjugates, Novel Therapeutics and Cytotoxics
    • +

      P01.01 - HERTHENA-Lung01: A Randomized Phase 2 Study of Patritumab Deruxtecan (HER3-DXd; U3-1402) in Previously Treated Metastatic EGFR-mutated NSCLC

      00:00 - 00:00  |  Presenting Author(s): Pasi A. Janne

      • Abstract

      Loading...

    • +

      P01.02 - Trastuzumab Deruxtecan Plus Pembrolizumab in Advanced/Metastatic Breast or Non-Small Cell Lung Cancer: A Phase 1b Study

      00:00 - 00:00  |  Presenting Author(s): Hossein Borghaei

      • Abstract

      Loading...

    • +

      P01.03 - Phase 1 Study of Patritumab Deruxtecan (HER3-DXd; U3-1402) in Combination with Osimertinib in Patients with Locally Advanced or Metastatic EGFR-mutated NSCLC

      00:00 - 00:00  |  Presenting Author(s): Pasi Antero Jänne

      • Abstract

      Loading...

    • +

      P01.04 - Dynamics of Molecular Markers in EGFR-Mutated NSCLC Patients Treated with Patritumab Deruxtecan (HER3-DXd; U3-1402)

      00:00 - 00:00  |  Presenting Author(s): Pasi Antero Jänne

      • Abstract

      Loading...

    • +

      P01.05 - Pilot Study of Inhaled Azacitidine in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)

      00:00 - 00:00  |  Presenting Author(s): Haiying Cheng

      • Abstract

      Loading...

    • +

      P01.06 - CX-2029, a Probody Drug Conjugate Targeting CD71 in Patients With Selected Tumor Types: PROCLAIM-CX-2029 Dose Expansion Phase

      00:00 - 00:00  |  Presenting Author(s): Melissa L Johnson

      • Abstract

      Loading...

    • +

      P01.07 - Real World Outcomes of Advanced Non-Small Cell Lung Cancer (NSCLC) With Attention to Carboplatin Area Under the Curve (AUC) = 5 Versus 6

      00:00 - 00:00  |  Presenting Author(s): Lindsey Fitzgerald

      • Abstract

      Loading...

    • +

      P01.08 - Evaluation of Long-Term Pemetrexed Responders in a United States Cohort

      00:00 - 00:00  |  Presenting Author(s): Sylvia Vania Alarcon

      • Abstract

      Loading...

    • +

      P01.09 - Improved Outcomes With Ramucirumab & Docetaxel in Metastatic Non-Small Cell Lung Cancer After Failure of Immunotherapy

      00:00 - 00:00  |  Presenting Author(s): Kunal Gawri

      • Abstract

      Loading...

    • +

      P01.10 - Patients Experienced Pseudoprogression to Anti-PD-1/PD-L1 Inhibitor Have Better Response Than Those Without in Lung Cancer

      00:00 - 00:00  |  Presenting Author(s): Wencheng Zhao

      • Abstract

      Loading...

    • +

      P01.11 - Clinical Outcomes After Discontinuation of Immunotherapy in Patients With Non-Progressing Metastatic Lung Cancer

      00:00 - 00:00  |  Presenting Author(s): Matias Alejandro Cerini

      • Abstract

      Loading...

    • +

      P01.12 - Brain Necrosis in Patients With Metastatic Lung and Breast Cancer Successfully Treated With Bevacizumab

      00:00 - 00:00  |  Presenting Author(s): Luis E. Raez

      • Abstract

      Loading...

    • +

      P01.13 - Anti-PD1 Inhibitors Combined With Anti-Angiogenesis Showed Superior Efficacy in Control of Malignant Pleural Effusion for NSCLC

      00:00 - 00:00  |  Presenting Author(s): Wencheng Zhao

      • Abstract

      Loading...

    • +

      P01.14 - Safety and Feasibility of Standard Dosing Carboplatin AUC 5 Every 3rd Weeks With Daily Navelbine® 20/30mg During 4 Cycles, Treating Advanced NSCLC

      00:00 - 00:00  |  Presenting Author(s): Maria Kandi

      • Abstract

      Loading...

    • +

      P01.15 - Immune-Related Adverse Effects of Immunotherapy in Patients With Advanced Non-Small Cell Lung Carcinoma

      00:00 - 00:00  |  Presenting Author(s): Cláudia Freitas

      • Abstract

      Loading...

    • +

      P01.16 - Tamoxifen Might Enhance the Effect of EGFR-TKIs on EGFR-Mutant NSCLC Cells

      00:00 - 00:00  |  Presenting Author(s): Yun-Ting He

      • Abstract

      Loading...

    • +

      P01.17 - An Exploratory Study of Associating Factors for Disease Progression After Response to Immune Checkpoint Inhibitor Monotherapy

      00:00 - 00:00  |  Presenting Author(s): Osamu Kanai

      • Abstract

      Loading...

    • +

      P01.18 - Adjuvant Chemotherapy With Modified Nab-Paclitaxel and Carboplatin for Completely Resected NSCLC: Survival Analysis of FAST-Nab.

      00:00 - 00:00  |  Presenting Author(s): HISASAHI Saji

      • Abstract

      Loading...

    • +

      P01.19 - Real-World Treatment Patterns in Treatment-Naïve Advanced NSCLC Patients in Asia: A Systematic Literature Review

      00:00 - 00:00  |  Presenting Author(s): Adam Lee

      • Abstract

      Loading...

    • +

      P01.20 - Short-Term Effificacy of Intrapleural Hyperthermic Perfusion for Malignant Pleural Effusion in Lung Carcinoma

      00:00 - 00:00  |  Presenting Author(s): Minhua Ye

      • Abstract

      Loading...

    • +

      P01.21 - ANSELMA: Antiangiogenic Second Line Lung Cancer Meta-Analysis on Individual Patient Data in Non-Small Cell Lung Cancer, Again Relevant in ICI Era

      00:00 - 00:00  |  Presenting Author(s): Jordi Remon

      • Abstract

      Loading...

    • +

      P01.22 - Outcomes in NSCLC Patients with Early Termination of Immune Checkpoint Inhibitors Due to Toxicities

      00:00 - 00:00  |  Presenting Author(s): Amy Georgina Davies

      • Abstract

      Loading...

    • +

      P01.23 - Veliparib (V) in Combination with Carboplatin/Paclitaxel (C/P)-Based Chemoradiotherapy (CRT) in Patients With Stage III NSCLC

      00:00 - 00:00  |  Presenting Author(s): David Kozono

      • Abstract

      Loading...

    • +

      P01.24 - Ramucirumab + Docetaxel (DOC) vs PBO + DOC for Stage IV NSCLC after Disease Progression (REVEL): Indian Sub-Group Analysis

      00:00 - 00:00  |  Presenting Author(s): Kumar Prabhash

      • Abstract

      Loading...

  • +

    P02 - Diagnostics and Interventional Pulmonology

    • 00:00 - 00:00
    • 1/28/2021
    • Location: ePoster Hall
    • Not for CME Credit
    • Type: Posters
    • Track: Diagnostics and Interventional Pulmonology
    • +

      P02.01 - Evaluation of PFS for Pulmonary Adenocarcinoma Patient Treated With EGFR Tyrosine Kinase Inhibitors Using Deep Learning Based on CT Image

      00:00 - 00:00

      • Abstract

      Loading...

    • +

      P02.02 - Pulmonary Rebiopsy is ‘Here to Stay’ in Non-Small Cell Lung Carcinoma (NSCLC) Patients with Progression on Tyrosine Kinase Inhibitors (TKIs)

      00:00 - 00:00  |  Presenting Author(s): Abhishek Bansal

      • Abstract

      Loading...

    • +

      P02.03 - Comparison of the Efficiency of 22G Versus 25G Needle in EBUS-TBNA for Diagnosis of Lung Cancer; A Prospective Randomized, Crossover Study.

      00:00 - 00:00  |  Presenting Author(s): Tetsuya Sakai

      • Abstract

      Loading...

    • +

      P02.04 - Pectoral Muscle Area Correlates with LENT Score in Non-Small Cell Lung Cancer Associated Pleural Effusion Survival Prediction

      00:00 - 00:00  |  Presenting Author(s): Austin Michael Meggyesy

      • Abstract

      Loading...

    • +

      P02.05 - A Nomogram to Predict Survival in Non-Small Cell Lung Cancer Patients Receiving Atezolizumab: An Analysis of OAK and POPLAR Cohorts

      00:00 - 00:00  |  Presenting Author(s): Haiyong Wang

      • Abstract

      Loading...

    • +

      P02.06 - A Novel Loop-Mediated Isothermal Amplification Method for Robust Detection of EGFR Mutations

      00:00 - 00:00  |  Presenting Author(s): YUICHI Saito

      • Abstract

      Loading...

    • +

      P02.07 - Impact of Diagnostic Test Sequencing on Effectiveness, Efficiency and Survival in Metastatic Non-Small Cell Lung Cancer.

      00:00 - 00:00  |  Presenting Author(s): Prachi Bhave

      • Abstract

      Loading...

    • +

      P02.08 - A UK Survey of Current Methods for Conducting Cancer Multidisciplinary Team Meetings and Opportunities for Digital Solutions.

      00:00 - 00:00  |  Presenting Author(s): Clarissa Gardner

      • Abstract

      Loading...

    • +

      P02.09 - Comprehensive Investigation of Resected Benign Lesions Suspected for Lung Cancer: Implications for Avoiding Unnecessary Pulmonary Resection

      00:00 - 00:00  |  Presenting Author(s): Zelin Ma

      • Abstract

      Loading...

    • +

      P02.10 - Patterns of Care for Elderly Patients over Age 80 with Stage IIIA-N2, IIIB, and IIIC NSCLC

      00:00 - 00:00  |  Presenting Author(s): Yajie Yin

      • Abstract

      Loading...

    • +

      P02.11 - Treatment Strategy for Postoperative Chylothorax after Lung Cancer Surgery

      00:00 - 00:00  |  Presenting Author(s): Chihaya Maeda

      • Abstract

      Loading...

    • +

      P02.12 - Is there a Need for Staging EBUS in Lung Cancer? 

      00:00 - 00:00  |  Presenting Author(s): Avinash Aujayeb

      • Abstract

      Loading...

    • +

      P02.13 - Pneumothorax and CT Guided Biopsy for the Investigation of Lung Cancer

      00:00 - 00:00  |  Presenting Author(s): Avinash Aujayeb

      • Abstract

      Loading...

    • +

      P02.14 - Radiotherapy-Associated CT Imaging as a Potential Screening Tool for COVID-19

      00:00 - 00:00  |  Presenting Author(s): Abraham J Wu

      • Abstract

      The abstract for this presentation is currently under embargo or has not been submitted.

    • +

      P02.15 - Intraparenchymal Blood Patch after CT Guided Biopsy of  Lung and Mediastinal Lesions Reduces the Risk of Pneumothorax

      00:00 - 00:00  |  Presenting Author(s): Binoy Kumar Choudhury

      • Abstract

      Loading...

    • +

      P02.16 - Rigid Medical Thoracoscopy in a Large UK District General Hospital

      00:00 - 00:00  |  Presenting Author(s): Avinash Aujayeb

      • Abstract

      Loading...

    • +

      P02.17 - Feasibility and Safety of ENB Guided Microwave Ablation for Lung Cancer: A Preliminary Report

      00:00 - 00:00  |  Presenting Author(s): Feichao Bao

      • Abstract

      Loading...

    • +

      P02.18 - Indwelling Pleural Catheter Placement in a Large UK District General Hospital

      00:00 - 00:00  |  Presenting Author(s): Avinash Aujayeb

      • Abstract

      Loading...

    • +

      P02.19 - Prognostic Nomogram for Advanced Non-Small Cell Lung Cancer Patients Treated With Anti-PD-1 Inhibitors

      00:00 - 00:00  |  Presenting Author(s): Rong Chai

      • Abstract

      Loading...

    • +

      P02.20 - Does Response at 1st Scan Imaging After Any Line Correlate With PFS?

      00:00 - 00:00  |  Presenting Author(s): FADI Nasr

      • Abstract

      Loading...

    • +

      P02.21 - The Impact of Inflammatory Serum Biomarkers in Non-Small Cell Lung Cancer Patients Treated With Immune Checkpoint Inhibitors

      00:00 - 00:00  |  Presenting Author(s): Élia Rodrigues Cipriano

      • Abstract

      Loading...

    • +

      P02.22 - Identification of FGFR Mutations in Chinese Lung Cancer Patients by Next-Generation Sequencing

      00:00 - 00:00  |  Presenting Author(s): HONGXIA Ma

      • Abstract

      Loading...

    • +

      P02.23 - Robotic Thoracic Surgery - A Comparison of Age-Groups Outcomes.

      00:00 - 00:00  |  Presenting Author(s): Rui Haddad

      • Abstract

      Loading...

    • +

      P02.24 - Liquid Biopsy Mutation Profiling in Non-Small Cell Lung Cancer

      00:00 - 00:00  |  Presenting Author(s): Vaida Gedvilaitė

      • Abstract

      Loading...

    • +

      P02.25 - Coexistence of Invasive Adenocarcinoma, Minimally Invasive Adenocarcinoma and Atypical Adenomatous Hyperplasia: A Case Report

      00:00 - 00:00  |  Presenting Author(s): Kewei Ma

      • Abstract

      Loading...

  • +

    P03 - Early Stage/Localized Disease - Clinical Trials in Progress

    • 00:00 - 00:00
    • 1/28/2021
    • Location: ePoster Hall
    • Not for CME Credit
    • Type: Posters
    • Track: Early Stage/Localized Disease
    • +

      P03.01 - A Randomized Phase II Trial of Adjuvant Pembrolizumab vs Observation after Curative Resection for Stage I NSCLC with Primary Tumors Between 1-4 cm

      00:00 - 00:00  |  Presenting Author(s): Gregory A Durm

      • Abstract

      Loading...

    • +

      P03.02 - Neoadjuvant Osimertinib with/without Chemotherapy vs Chemotherapy for EGFR Mutated Resectable NSCLC: NeoADAURA 

      00:00 - 00:00  |  Presenting Author(s): Masahiro Tsuboi

      • Abstract

      Loading...

    • +

      P03.03 - MERMAID-1: A Phase III Study of Adjuvant Durvalumab plus Chemotherapy in Resected NSCLC Patients with MRD+ Post-Surgery

      00:00 - 00:00  |  Presenting Author(s): Solange Peters

      • Abstract

      Loading...

    • +

      P03.04 - Phase II Study of TKIs as Neo(adjuvant) Therapy in Stage II–III Resectable NSCLC with ALK, ROS1, NTRK or BRAFV600 Alterations

      00:00 - 00:00  |  Presenting Author(s): Jay M. Lee

      • Abstract

      Loading...

    • +

      P03.05 - CANOPY-N: Neoadjuvant Canakinumab and Pembrolizumab in Patients With Surgically Resectable Non-Small Cell Lung Cancer

      00:00 - 00:00  |  Presenting Author(s): Jay M. Lee

      • Abstract

      Loading...

    • +

      P03.06 - Nausea in Patients Had Thoracomy: A Pilot Study

      00:00 - 00:00  |  Presenting Author(s): Feng-Ming (Spring) Kong

      • Abstract

      Loading...

  • +

    P04 - Early Stage/Localized Disease - Perioperative Therapy (Neoadjuvant Therapy, Surgery, Adjuvant Therapy)

    • 00:00 - 00:00
    • 1/28/2021
    • Location: ePoster Hall
    • Not for CME Credit
    • Type: Posters
    • Track: Early Stage/Localized Disease
    • +

      P04.01 - Adjuvant Chemotherapy is not Associated with Worse Disease-Free Survival in the Elderly Population.  

      00:00 - 00:00  |  Presenting Author(s): Luciana Beatriz Mendes Gomes

      • Abstract

      Loading...

    • +

      P04.02 - Three Definitions of Normal Lung Volumes for Predicting Radiation Pneumonitis in Advanced NSCLC Treated With Radical Chemoradiation Therapy

      00:00 - 00:00  |  Presenting Author(s): zhiyong Chen

      • Abstract

      Loading...

    • +

      P04.03 - Patient Characteristics and Clinical Outcomes of Stage III NSCLC in a Real-World Setting: KINDLE Korean Subset Data.

      00:00 - 00:00  |  Presenting Author(s): Byoung Chul Cho

      • Abstract

      Loading...

    • +

      P04.04 - Thrombus Formation at Stump of Pulmonary Vein after Pulmonary Lobectomy: A Prospective Multi-institutional Study

      00:00 - 00:00  |  Presenting Author(s): Takayoshi Yamamoto

      • Abstract

      Loading...

    • +

      P04.05 - Efficacy of Uniportal Video-Assisted Thoracic Surgery (U-VATS) Simple Segmentectomy for Early Lung Cancer

      00:00 - 00:00  |  Presenting Author(s): Kyoji Hirai

      • Abstract

      Loading...

    • +

      P04.06 - Early Surgical and Oncological Outcomes After Single Port Video Assisted Thoracoscopic Surgery Lung Resection; KHCC Experience

      00:00 - 00:00  |  Presenting Author(s): riad Amin Abdeljalil

      • Abstract

      Loading...

    • +

      P04.07 - Long-term Postoperative Prognosis of Adenocarcinoma in Situ and Minimally Invasive Adenocarcinoma of Lung

      00:00 - 00:00  |  Presenting Author(s): Masaya Yotsukura

      • Abstract

      Loading...

    • +

      P04.08 - Dynamics of Coagulation Factor XIII Activity After Thoracoscopic Lobectomy for Early-Stage Lung Cancer Patients

      00:00 - 00:00  |  Presenting Author(s): Yoshikane Yamauchi

      • Abstract

      Loading...

    • +

      P04.09 - Real-Time CT Guided Video-Assisted Thoracoscopic Partial Resection of Peripheral Small-Sized Lung Tumors in Hybrid OR –A Phase 2 Trial–

      00:00 - 00:00  |  Presenting Author(s): Taisuke Kaiho

      • Abstract

      Loading...

    • +

      P04.10 - Relapsed or Metastatic Organotropism in Early Stage Lung Cancer after Radical Surgery

      00:00 - 00:00  |  Presenting Author(s): Fei Xu

      • Abstract

      Loading...

    • +

      P04.11 - Sublobar Resection Versus Lobectomy For Early Stage Pulmonary Carcinoid Tumors With 3 cm Or Less In Size: A Population-Based Study

      00:00 - 00:00  |  Presenting Author(s): Xiongfei Li

      • Abstract

      Loading...

    • +

      P04.12 - A Novel Lung Autotransplantation Technique for Treating Central Lung Cancer and Bronchial Malignancy

      00:00 - 00:00  |  Presenting Author(s): JIAXI He

      • Abstract

      Loading...

  • +

    P05 - Early Stage/Localized Disease - Radiotherapy

    • 00:00 - 00:00
    • 1/28/2021
    • Location: ePoster Hall
    • Not for CME Credit
    • Type: Posters
    • Track: Early Stage/Localized Disease
    • +

      P05.01 - Multicenter Retrospective Study of Stereotactic Body Radiotherapy in Non-Small Cell Lung Cancer in South Korea (KROG 17-09)

      00:00 - 00:00  |  Presenting Author(s): Seung Gyu Park

      • Abstract

      Loading...

    • +

      P05.02 - International Delphi Consensus on Radical Thoracic Re-Irradiation for Non-Small Cell Lung Cancer (NSCLC)

      00:00 - 00:00  |  Presenting Author(s): Robert Rulach

      • Abstract

      Loading...

    • +

      P05.03 - Circulating Lymphocyte Counts after Lung Stereotactic Body Radiation Therapy May Predict after Optimal Short-term Efficacy

      00:00 - 00:00  |  Presenting Author(s): Meng Chen

      • Abstract

      Loading...

    • +

      P05.04 - Association of Lymphopenia and Disease Progression in Unresectable NSCLC Treated with Definitive Chemoradiation and Immunotherapy

      00:00 - 00:00  |  Presenting Author(s): Cole Friedes

      • Abstract

      Loading...

    • +

      P05.05 - Real-World Data on Patients With Stage I Non-Small Cell Lung Cancer Treated With Stereotactic Body Radiotherapy (SBRT)

      00:00 - 00:00  |  Presenting Author(s): Lisa Van Der Woude

      • Abstract

      Loading...

    • +

      P05.06 - Stereotactic Ablative Radiotherapy for Early Stage Non-Small Lung Cancer and Pulmonary Oligometastases in a New Zealand Population

      00:00 - 00:00  |  Presenting Author(s): Nur Azri Bin Haji Mohd Yasin

      • Abstract

      Loading...

    • +

      P05.07 - Single-Fraction Carbon ion Radiotherapy for Patients with Early-Stage Lung Cancer with or without Interstitial Pneumonitis

      00:00 - 00:00  |  Presenting Author(s): Takashi Ono

      • Abstract

      Loading...

    • +

      P05.08 - A Propensity Score-Weighted Analysis for SBRT, Lobectomy and Sublobar Resection in Elderly Patients with cStage I NSCLC

      00:00 - 00:00  |  Presenting Author(s): Noriko Kishi

      • Abstract

      Loading...

    • +

      P05.09 - Thoracic Re-Irradiation Dose Constraints for Late Lung Fibrosis: Preliminary Modelling Results

      00:00 - 00:00  |  Presenting Author(s): Robert Rulach

      • Abstract

      Loading...

    • +

      P05.10 - Risk Factors Associated with Pulmonary Toxicities from Multiple Courses of Lung Stereotactic Body Radiation Therapy (SBRT)

      00:00 - 00:00  |  Presenting Author(s): Xingzhe Li

      • Abstract

      Loading...

    • +

      P05.11 - Preoperative Low Muscle Quality Predicts Poor Outcomes After Surgery for Early-Stage Non-Small Cell Lung Cancer

      00:00 - 00:00  |  Presenting Author(s): Atsushi Kamigaichi

      • Abstract

      Loading...

    • +

      P05.12 - Hospitalisation Rate in Radical Re-Irradiation of NSCLC are no Different Between Local Recurrences or Second Primaries

      00:00 - 00:00  |  Presenting Author(s): Robert Rulach

      • Abstract

      Loading...

    • +

      P05.13 - Central vs Peripheral Thoracic Malignancies Treated with SBRT: Early Outcomes of a Prospective Quality of Life Study

      00:00 - 00:00  |  Presenting Author(s): Michael Carrasquilla

      • Abstract

      Loading...

    • +

      P05.14 - Dosimetric Impact of Using the Acuros XB for Planning of SBRT of Centrally Located NSCLC

      00:00 - 00:00  |  Presenting Author(s): Hing Ming Hung

      • Abstract

      Loading...

    • +

      P05.15 - Assessment of Short-Term SBRT Effect in Early Stage Lung Cancer Patients Based on CBCT Radiomics

      00:00 - 00:00  |  Presenting Author(s): Liqiao Hou

      • Abstract

      Loading...

  • +

    P06 - Early Stage/Localized Disease - Multiple Primary Lung Cancer

    • 00:00 - 00:00
    • 1/28/2021
    • Location: ePoster Hall
    • Not for CME Credit
    • Type: Posters
    • Track: Early Stage/Localized Disease
    • +

      P06.01 - Therapeutic Strategies for Metachronous Multiple Primary Lung Cancer

      00:00 - 00:00  |  Presenting Author(s): Jitsuo Usuda

      • Abstract

      Loading...

    • +

      P06.02 - Prognostic Factors and Strategies for Metachronous Second Primary Lung Cancer

      00:00 - 00:00  |  Presenting Author(s): Dai Shimizu

      • Abstract

      Loading...

    • +

      P06.03 - Regression of the Ground Glass Component in Patients with Multifocal Primary Lung Cancers Receiving Pembrolizumab

      00:00 - 00:00  |  Presenting Author(s): Jessica Li

      • Abstract

      Loading...

    • +

      P06.04 - Single-Stage Bilateral Pulmonary Resections by Uniportal Video-Assisted Thoracic Surgery for Multiple Small Nodules

      00:00 - 00:00  |  Presenting Author(s): Xiaotong Guo

      • Abstract

      Loading...

  • +

    P07 - Early Stage/Localized Disease - Imaging and Biomarkers

    • 00:00 - 00:00
    • 1/28/2021
    • Location: ePoster Hall
    • Not for CME Credit
    • Type: Posters
    • Track: Early Stage/Localized Disease
    • +

      P07.01 - Less Accuracy of CT and PET in the Evaluation of N1 Node may Result in Overlooking Skip Metastasis of Single Station cN2 Non-Small Cell Lung Cancer

      00:00 - 00:00  |  Presenting Author(s): Satoshi Shiono

      • Abstract

      Loading...

    • +

      P07.02 - Detection of Molecular Residual Disease (MRD) using ctDNA in NSCLC: A Systematic Review and Meta-Analysis

      00:00 - 00:00  |  Presenting Author(s): Antonio Galvano

      • Abstract

      Loading...

    • +

      P07.03 - The Impact of PD-L1 Expression on the Prognosis of Early-Stage Resected NSCLC: A Meta-Analysis of Literatures.

      00:00 - 00:00  |  Presenting Author(s): Shuai Zhu

      • Abstract

      Loading...

    • +

      P07.04 - Using ctDNA to Detect Minimal Residual Disease after Surgery in Resectable Lung Cancer

      00:00 - 00:00  |  Presenting Author(s): Jun Huang

      • Abstract

      Loading...

    • +

      P07.05 - Characterization of Clinicopathologic Features and Molecular Recurrence Risk Profiles in Patients with Early-Stage NSCLC

      00:00 - 00:00  |  Presenting Author(s): Sara Riordan

      • Abstract

      Loading...

    • +

      P07.06 - Automated Flow Cytometry Test Distinguishes Cancer from Non-Cancer in Sputum with High Sensitivity and Specificity

      00:00 - 00:00  |  Presenting Author(s): Vivienne Ilona Rebel

      • Abstract

      Loading...

    • +

      P07.07 - Computed Tomography of Lymph Nodes to Predict Occult pN2 Disease in Non-Small-Cell Lung Cancer

      00:00 - 00:00  |  Presenting Author(s): Hiroto Onozawa

      • Abstract

      Loading...

    • +

      P07.08 - IDO Immune Suppression and Post Surgical Toxicity in Patients with Non-Small Cell Lung Cancer

      00:00 - 00:00  |  Presenting Author(s): Dazhi Pang

      • Abstract

      Loading...

  • +

    P08 - Early Stage/Localized Disease - Epidemiology

    • 00:00 - 00:00
    • 1/28/2021
    • Location: ePoster Hall
    • Not for CME Credit
    • Type: Posters
    • Track: Early Stage/Localized Disease
    • +

      P08.01 - Prognostic Impact of Second Predominant Pattern in Lung Adenocarcinoma: Analysis From a Large Multicentric European Database

      00:00 - 00:00  |  Presenting Author(s): Pietro Bertoglio

      • Abstract

      Loading...

    • +

      P08.02 - Lung Cancer Risk in Liver Transplant Recipients: A Meta-Analysis

      00:00 - 00:00  |  Presenting Author(s): Zhenyu Huo

      • Abstract

      Loading...

    • +

      P08.03 - Clinicopathological Factors Associated With Recurrence Patterns of Resected Non-Small Cell Lung Cancer

      00:00 - 00:00  |  Presenting Author(s): Tomonari Kinoshita

      • Abstract

      Loading...

    • +

      P08.04 - Progress in Early Stage Lung Cancer Among Economically Disadvantaged Patients

      00:00 - 00:00  |  Presenting Author(s): Brendon Stiles

      • Abstract

      The abstract for this presentation is currently under embargo or has not been submitted.

    • +

      P08.05 - Risk Factors Associated with Recurrence Following Curative Therapy for Stage I NSCLC

      00:00 - 00:00  |  Presenting Author(s): Emily Brooke Butts

      • Abstract

      Loading...

    • +

      P08.06 - Factors Associated with the Diagnosis of Lymphatic Vascular Invasion and its Impact on Prognosis.

      00:00 - 00:00  |  Presenting Author(s): Christine M Hebert

      • Abstract

      Loading...

    • +

      P08.07 - Clinical Characteristics and Treatment Patterns of NSCLC Stage III Patients from Real World

      00:00 - 00:00  |  Presenting Author(s): Julia Roeper

      • Abstract

      Loading...

    • +

      P08.08 - Surgical Resection of Non-Small Cell Lung Cancer: Uncertain Resection Margins and Patterns of Recurrence

      00:00 - 00:00  |  Presenting Author(s): Hannah Emily Scholes

      • Abstract

      Loading...

    • +

      P08.09 - Optimal Follow Up Care for Patients with P-stage I Non-Small Cell Lung Cancer After Surgical Treatment

      00:00 - 00:00  |  Presenting Author(s): Hirotsugu Notsuda

      • Abstract

      Loading...

    • +

      P08.10 - Clinical Characteristics and Outcomes of Simultaneous Multiple Primary Lung Cancer with Same Pathological Types

      00:00 - 00:00  |  Presenting Author(s): Ying Liu

      • Abstract

      Loading...